Class III Malocclusion and ALT-RAMEC
Evaluation of the Effects of Alternating Rapid Maxillary Expansion and Facemask Use in Cases of Class III Malocclusion Caused by Maxillary Retrognathia- A Prospective, Randomized Clinical Trial
1 other identifier
interventional
40
1 country
1
Brief Summary
Diverse viewpoints exist regarding the correlation between the conventional rapid maxillary expansion (RME) and facemask approach and the alternative RME and facemask hybrid technique (Alt-RAMEC) in terms of the degree of maxillary protraction. The findings of the study may offer a novel approach to protocol selection based on the anomaly's degree of severity. The objective of this investigation is to assess and contrast the skeletal and dentoalveolar outcomes of three distinct Alt-RAMEC techniques.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2012
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 13, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 15, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
August 15, 2012
CompletedFirst Submitted
Initial submission to the registry
May 17, 2023
CompletedFirst Posted
Study publicly available on registry
June 22, 2023
CompletedJune 22, 2023
June 1, 2023
6 months
May 17, 2023
June 16, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Evaluation of Skeletal, Dental, and Soft Tissue Angular Measurements
Changes at the maxillary advancement, teeth positions and soft tissues amount were assessed in angular level. Skeletal measurements: Angular measurements: SNA (°), SNB (°), SN/S-Gn (Y-axis)(°), SN/Go-Gn (°), Ar-Go-Gn (°), SN/Go-Ar (°), and ANB (°) were measured. Dental measurements: Angular measurements: U1 to MaxP (°) for maxillary dentoalveolar measurements; L1-MandP (°) for mandibular dentoalveolar measurements; U1-L1 (°) for interdental measurements were performed. Soft tissue measurements: Changes at the upper and lower lip assessed. Angular measurements: G-Sn-Pg' (°), Nasolabial angle (°), and Labiomental angle (°) were measured.
6 months
Secondary Outcomes (1)
Evaluation of Skeletal, Dental, and Soft Tissue Millimetrical Measurements
6 months
Study Arms (3)
Investigation of the Effects of Alt-RAMEC and Facemask 1 week Use in Class III Malocclusion
EXPERIMENTALA sample of 40 patients, consisting of 18 males and 22 females with a mean age of 10.64 ± 0.98, who were in the growth and developmental stage, were divided into three treatment groups. The formation of groups was carried out with the aim of achieving a near-equal distribution of male and female participants within each group, as indicated in Table 1. The first group comprised 14 patients, while the second and third groups consisted of 13 patients each. The skeletal age of the individual was determined through the acquisition of hand-wrist X-rays and the application of the Greulich and Pyle atlas at T1.
Investigation of the Effects of Alt-RAMEC and Facemask 3 week Use in Class III Malocclusion
EXPERIMENTALThe second group comprised 13 patients who were in the growth and developmental stage. The skeletal age of the individual was determined through the acquisition of hand-wrist X-rays and the application of the Greulich and Pyle atlas at T1.
Investigation of the Effects of Alt-RAMEC and Facemask 5 week Use in Class III Malocclusion
EXPERIMENTALThe third group comprised 13 patients who were in the growth and developmental stage. The skeletal age of the individual was determined through the acquisition of hand-wrist X-rays and the application of the Greulich and Pyle atlas at T1.
Interventions
The study involved the fabrication of occlusal-coverage bonded type RME devices utilizing Hyrax screws (A0620-11, Leone S.p.A., Firenze, Italy). Each patient in Group 1 (classical RME method) was instructed to open Hyrax screw twice a day for a week. At the end of the respective periods (1 week), the screws were fixed with ligatures, and the patients were evaluated. Face-mask treatment was subsequently started after RME. Totaling 700 g of extraoral traction force applied to maxilla. Patients were advised to wear Delaire type facemasks (M0774-00, Leone SpA) 14-16 hours a day for 6 months.
The same fabrication of occlusal-coverage bonded type RME devices were utilized Hyrax screws (A0620-11, Leone S.p.A., Firenze, Italy) in Group 2. Each patient in Group 2 (3-week Alt-RAMEC protocol), the patients were instructed to activate Hyrax screw twice a day for one week, close the screw for following week, and open the screw over the third week. At the end of the respective periods (3 weeks), the screws were fixed with ligatures, and the patients were evaluated. Face-mask treatment was subsequently started after RME. Totaling 700 g of extraoral traction force applied to maxilla. Patients were advised to wear Delaire type facemasks (M0774-00, Leone SpA) 14-16 hours a day for 6 months.
The same fabrication of occlusal-coverage bonded type RME devices were utilized Hyrax screws (A0620-11, Leone S.p.A., Firenze, Italy) in Group 3. Each patient in Group 3 (5-week Alt-RAMEC protocol), the patients were instructed to activate Hyrax screw twice a day for one week, close the screw for following week, and open the screw over the third week. The aforementioned screw open-close procedure was implemented over a period of five weeks. At the end of the respective periods (5 weeks), the screws were fixed with ligatures, and the patients were evaluated. Face-mask treatment was subsequently started after RME. Totaling 700 g of extraoral traction force applied to maxilla. Patients were advised to wear Delaire type facemasks (M0774-00, Leone SpA) 14-16 hours a day for 6 months.
Eligibility Criteria
You may qualify if:
- Maxillary retrognathia (SNA ≤ 79°)
- Skeletal Class III malocclusion (ANB ≤ -1°)
- Anterior cross-bite
- Class III molar relationship
- Horizontal growth pattern (SN/Go-Gn \< 30°)
You may not qualify if:
- Previous orthodontic treatment
- Systemic disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Trakya Universitylead
- Istanbul Universitycollaborator
Study Sites (1)
Trakya University
Edirne, 22000, Turkey (Türkiye)
Study Officials
- STUDY DIRECTOR
Nilüfer Yılmaz Öğütlü, Dr.
Istanbul University
- PRINCIPAL INVESTIGATOR
Gülsün Külekçi Çakan
Private Practitioner
- STUDY CHAIR
Hülya Kılıçoğlu, Prof. Dr.
Istanbul University
- PRINCIPAL INVESTIGATOR
Hande Uzunçıbuk, Dr.
Trakya University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant Dr./ Principal Investigator
Study Record Dates
First Submitted
May 17, 2023
First Posted
June 22, 2023
Study Start
January 13, 2012
Primary Completion
July 15, 2012
Study Completion
August 15, 2012
Last Updated
June 22, 2023
Record last verified: 2023-06
Data Sharing
- IPD Sharing
- Will not share